Bryan Schwent, MD
Ophthalmology · Richmond, VANPI 1760494835
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $4,068 of the $6,652 with a category attached, or 61.1%. Carl Zeiss Meditec, Inc. accounts for 61.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $3,755 and has fallen 99.3% since, to $25 in 2025. Among ophthalmology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $665.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$4K
- Roche Diagnostics Corporation$2K
- Mallinckrodt Hospital Products Inc.$93
- AbbVie$71
- Novartis$20
Across 1 payment — averaging $1031.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$1K
What the payments were for
- Consulting fees$2,40036%
- Food & beverage$911%
- Education$931%
- Gifts$4,06861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 4 | $4,068 |
| Roche Diagnostics Corporation | 1 | $2,400 |
| Mallinckrodt Hospital Products Inc. | 1 | $93 |
| AbbVie | 3 | $71 |
| Novartis | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,652 in reported general payments places this provider in the 90th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 288 | $11,230 |
| Ketorolac Tromethamine | 204 | $4,448 |
| Ofloxacin | 51 | $540 |
| Timolol Maleate | 51 | $347 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 22 | $229 |
| Brimonidine Tartrate | 28 | $212 |
| Dorzolamide Hcl | 13 | $200 |
| Latanoprost | 20 | $153 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Richmond
- Ethnie JonesRichmond$2M
- Thomas JenkinsRichmond$26K
- Jessica RandolphRichmond$18K
- Nikisha RichardsRichmond$16K
- Tam DangRichmond$9K
- Byron LaddRichmond$7K
- Rishi ParikhRichmond$6K
- Elizabeth Yeu-LinNorfolk$1.7M
- John SheppardNorfolk$1.1M
- Constance OkekeNorfolk$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.